Comparison between Lohia Corp IPO and Molbio Diagnostics IPO.
Lohia Corp IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Molbio Diagnostics IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Lohia Corp IPO is up to ₹0.00 Cr whereas the issue size of the Molbio Diagnostics IPO is up to ₹0.00 Cr. The final issue price of Lohia Corp IPO is and of Molbio Diagnostics IPO is .
| Lohia Corp IPO | Molbio Diagnostics IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹1 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹200.00 Cr |
| OFS Issue Size | 4,22,59,970 shares | 1,25,56,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 4,22,59,970 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Lohia Corp IPO opens on , while Molbio Diagnostics IPO opens on . The closing date of Lohia Corp IPO and Molbio Diagnostics IPO is , and , respectively.
Lohia Corp IPO P/E ratio is , as compared to Molbio Diagnostics IPO P/E ratio of .
| Lohia Corp IPO | Molbio Diagnostics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)Molbio Diagnostics Ltd.'s revenue increased by 22% and profit after tax (PAT) rose by 66% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 93 | 46.65 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 31.71% | 16.20% | ||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 30.45% | 20.98% | ||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.47 | |||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.29 | |||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 106.11% | 15.23% | ||||||||||||||||||||||||||||||||||||||||||||||||
In the Lohia Corp IPO Retail Individual Investors (RII) are offered 0 shares while in Molbio Diagnostics IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Lohia Corp IPO and 0 shares in Molbio Diagnostics IPO.
| Lohia Corp IPO | Molbio Diagnostics IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Lohia Corp IPO subscribed in total, whereas Molbio Diagnostics IPO subscribed .
